WealthCollab’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2K Hold
1,106
0.01% 442
2025
Q4
$19.9K Hold
1,106
0.01% 395
2025
Q3
$20.5K Hold
1,106
0.01% 354
2025
Q2
$17.7K Hold
1,106
0.01% 357
2025
Q1
$21.5K Hold
1,106
0.01% 304
2024
Q4
$24.4K Hold
1,106
0.02% 271
2024
Q3
$18.6K Hold
1,106
0.01% 325
2024
Q2
$13.2K Hold
1,106
0.01% 384
2024
Q1
$12.3K Sell
1,106
-236
-18% -$2.41K 0.01% 397
2023
Q4
$11.6K Buy
+1,342
New +$10.4K 0.01% 378

Other funds holding CLBT

WealthCollab's CLBT Position: Q1 2026 in Review

WealthCollab held its Cellebrite (CLBT) position steady in Q1 2026 at 1,106 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #442.

WealthCollab first reported a position in CLBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $24.4K in Q4 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • WealthCollab held 1,106 shares of Cellebrite worth $15.2K as of Q1 2026.
  • WealthCollab left its Cellebrite share count unchanged in Q1 2026.
  • Cellebrite made up 0.01% of WealthCollab's portfolio in Q1 2026, its #442 holding.
  • WealthCollab first reported a position in Cellebrite in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Cellebrite position peaked at $24.4K in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.